HomeLarge Type Edition
HOME ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
PubMed
Right arrow PubMed Citation
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 58:M468-M471 (2003)
© 2003 The Gerontological Society of America

Elective Primary Total Hip Arthroplasty in Octogenarians

L. Daniel Wurtz, Judy R. Feinberg, William N. Capello, Russell Meldrum and Patrick J. Kay

Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis.


    Abstract
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
Background. Total hip arthroplasty (THA) has resulted in decreased pain and increased function in people with end-stage hip arthritis for several decades. In elderly people, THA has been used most often following femoral neck fracture. However, with life spans increasing and people remaining healthy and active well into their eighties, arthroplasty surgeons are now performing primary THA as an elective procedure in octogenarians. The aim of this study was to demonstrate the efficacy of elective total hip arthroplasty in patients aged 80 years or older with end-stage hip arthritis.

Methods. Forty patients (46 THAs), aged 80 or older at the time of surgery, were identified for this study. Clinical assessment included amount of hip pain, limp, and use of assistive devices for ambulation at most recent follow-up. Radiographic assessment included implant stability, heterotopic bone formation, and osteolysis. Medical and hip-related complications, reoperations, and revisions were recorded from medical records.

Results. Eleven patients (27.5%) suffered a medical complication and six patients (15%) had a hip-related complication, all of which were treated and were not life threatening. Clinically, 80% were pain free and 70% walked without assistance at an average 4-year follow-up. Radiographically, all implants were stable without osteolysis. No components had been revised; however, four patients had undergone a reoperation, three for recurrent dislocation.

Conclusions. Elective total hip arthroplasty is a safe and effective treatment for end-stage osteoarthritis of the hip in the elderly patient. However, the procedure is not without risk. Complications, often related to preexisting comorbidities, do occur, but mortality rates are low.

TOTAL hip arthroplasty (THA) has been shown to be a safe and effective procedure for the treatment of patients with end-stage hip arthritis for the past four decades. The procedure is associated with low complication rates and significant improvements in comfort and functional status. (1). In addition, the procedure is considered cost effective (2). As a testament to the ability to decrease pain and improve function, over 100,000 such procedures are currently preformed annually in the United States (3).

Historically, most patients undergoing THA were in their sixties or seventies, with a more recent focus on the efficacy of the procedure in younger patients in their fifties or younger. Yet the most rapidly growing segment of the U.S. population is the age group older than 80 years (4). There are currently over 15 million people over the age of 80 years, and it is estimated that 1–3% of those older than the age of 65 will require hip replacement for relief of arthritic pain and disability (5,6). As a result, the number of patients over the age of 80 years needing hip replacement surgery is increasing. Issues related to elective THA in elderly people include higher incidence of medical and arthroplasty-related complications, increased mortality, functional outcome, life expectancy, and cost utility. Thus, the question is, How safe and effective is an elective THA for this age group?

The purpose of this study is (a) to report the clinical and radiographic results of a series of patients who were 80 years or older at the time of elective THA, and (2) to discuss the indications and contraindications specific to this population with regard to referral from the primary care physician to the orthopedic surgeon.


    Methods
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The study group was culled from the database of an arthroplasty surgeon at a major midwestern medical center. Inclusion criteria for this retrospective study included having a primary THA that used a cemented femoral component and a cementless acetabular component (so-called hybrid THA), being aged 80 years or more at time of surgery, receiving a diagnosis of degenerative joint disease, and experiencing a minimum of 2 years since the time of the arthroplasty procedure. Patients who had undergone hip arthroplasty following hip fracture were excluded. Therefore, the hip surgery was an elective procedure in all cases.

Each patient's physical status was rated at the time of surgery according to the American Society of Anesthesiologists (ASA) physical status classification (7). Medical chart reviews were done to determine the length of hospital stay, comorbidities, and incidence and type (medical or hip related) of perioperative complications. Late complications were also noted. Most recent clinical and radiographic follow-ups were used to determine outcome. If a patient did not have current follow-up, he or she was contacted and asked to come in for clinical and radiographic reassessment. If the patient was unable or declined to return for complete assessment, a clinical assessment was completed by telephone with the patient or close relative. Clinical evaluation included assessment of hip pain, limp, and use of ambulatory aids. Radiographic evaluation included assessment of implant stability, heterotopic bone formation, and osteolysis according to accepted standards of assessment (8–10). The number of and reasons for any reoperations or revision procedures were recorded.


    Results
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The study group consists of 40 patients (21 female and 19 male subjects) who underwent 46 primary hybrid THAs. The average age at the time of surgery was 83 (range 80–92 years). Twenty-one patients were married and 19 were widowed, with all but 2 patients in independent living situations (2 female patients resided in assisted living at the time of the hip surgery).

Of the 6 patients who had both hips replaced, 2 were done within the same hospitalization 1 week apart and the others ranged from 8 months to 3.5 years between procedures. Average length of hospitalization was 7.7 days (range 3–20 days), including the 12 and 15 days, respectively, for the 2 patients who underwent bilateral hip replacements during the same hospitalization. The average number of comorbidities was 2.2 (range 0–6). The most common medical conditions were hypertension in 24 patients and some form of heart disease in 20 patients. Physical status according to ASA classification at the time of each hip procedure was as follows: 1 ASA-1, 16 ASA-2, and 28 ASA-3. One patient's medical record was incomplete; therefore, ASA classification could not be determined.

Following surgery, 11 patients (27.5%) suffered a medical complication, none of which were life threatening. The most common postoperative complication was transient confusion in 5 patients. Other complications seen were single incidences of atrial fibrillation, gastrointestinal bleed, ileus, urinary tract infection, stable angina, chest pain (15 minutes duration with no electrocardiographic changes), mild dyspnea, and an ischial decubitus ulcer. Six patients (15%) had hip-related complications, including five cases of dislocation, and one each of infection/hematoma, heel ulcer, and peroneal nerve palsy.

At the time of completion of this follow-up study, 19 patients (47.5%) had died, including 2 patients who had bilateral hip arthroplasties. The average time to death was 63.5 months after hip replacement (range 1.8–140.3 months). Three patients died less than 2 years after the hip surgery, 1 during the perioperative or rehabilitation period. The perioperative death was secondary to sepsis from a chronic urinary tract infection and was not directly related to the hip surgery.

Average clinical follow-up was 47.5 months (range 1–127.6 months). Thirty-one patients were assessed by the surgeon in the clinic, and clinical assessment was done by telephone interview with the 9 other patients. Of the 46 hips, 37 caused no pain (80%). Four caused mild and five caused moderate pain. Twenty-eight patients walked without assistance (70%); 8 used a cane (4 as a result of the hip), 3 used a walker, and 1 was unable to walk.

Average radiographic follow-up was 38.9 months (range 1–127.6 months). All implants were radiographically stable at latest follow-up, with no evidence of osteolysis (Figure 1). Three hips showed evidence of heterotopic ossification, none of which was symptomatic. No patients had undergone component revision. Four patients had undergone reoperation. Two hips required conversion to a constrained liner to prevent recurrent dislocation, and 1 other patient had repositioning of the acetabular component with exchange of the polyethylene liner secondary to dislocation. One patient had a incision and drainage procedure secondary to wound dehiscence.



View larger version (82K):
[in this window]
[in a new window]
 
Figure 1. Elective primary total hip arthroplasty in octogenarians: A, preoperative x-ray of an 80-year-old man, showing advanced osteoarthritis of the left hip; B, postoperative x-ray showing the total hip arthroplasty (porous-coated Omnifit cup, cemented Omnifit stem, Osteonics Corporation, Allendale, NJ); C, D, and E, 1-, 7-, and 10-year follow-up x-rays showing stable implants. The patient died 11 years after surgery

 

    Discussion
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 
The results of this series of 40 patients, all of whom were aged 80 years or older at the time of surgery, indicate that elective THA is efficacious. The majority of patients were pain free and ambulated without an assistive device at an average 4 years after surgery. No patient suffered a life-threatening complication, and all patients had stable implants at the most recent follow-up.

One of the major concerns with performing surgery in an elderly patient is the increased risk of complications, caused by an increasing prevalence of comorbidities that come with advancing age (11,12). The prevalence of comorbidities was evidenced by the ASA ratings in this patient group, with just 1 patient free of any systemic disease. Eleven patients experienced medical complications postoperatively, none of which resulted in mortality. This medical complication rate (27.5%) is similar to that in other elderly patients following elective THA. Keisu and colleagues (13), in a series of 114 elderly patients, reported a 24% rate of medical complications, and Brander and associates (14) found no difference in rate of medical complications between groups of patients aged 65 to 79 and those over the age of 80 who underwent either THA or total knee arthroplasty. Imamura and Black (15), in a study aimed at assessing the impact of comorbidities on surgical outcome, found that comorbidities were a significant determinant of serious complications following THA. However, they also found that the presence of comorbidities did not negatively influence functional outcome.

Certain arthroplasty-related complications may also be higher in elderly people. Woolson and Rahimtoola (16) reported a trend toward an increased incidence of dislocation with increasing age. Age alone may not be the critical factor, as other studies report increased rates of dislocation in female subjects (17–19) and in those with altered mental status postoperatively (20), and both of these factors are seen with greater frequency in the elderly patient undergoing elective THA. Dislocation rates in other studies of primary THA in patients over the age of 80 ranged from less than 1% to 15% (13,14,21–24). Three hips or patients (6.5%) in this study required a reoperation as a result of recurrent dislocation.

A review of Medicare records between 1983 and 1985 indicated a perioperative (30-day) mortality rate of 0.95% for all patients over the age of 65 undergoing hip surgery for reasons other than hip fracture (25). The rate increased by age group, with a mortality rate of 3.75% in those patients over the age of 85. One patient in this study died approximately 6 weeks postoperatively as a result of a preexisting, chronic, urinary tract infection that became systemic. Phillips and colleagues (22), in 1987, reported two perioperative deaths in 100 consecutive cases of elderly patients undergoing THA, one secondary to a myocardial infarction and one as a result of a pulmonary embolus. However, more recent reports have reported no cases of deaths in the perioperative period following hip arthroplasty in elderly patients (13,14,21). In fact, Ritter and associates (26) recently reported a significantly greater 10-year life expectancy in elderly patients who have undergone THA than in the age-matched general population. Thus, it is concluded that THA is currently a safe procedure for elderly patients.

With regard to functional outcome and health-related quality of life, in a large series of patients undergoing THA or total knee arthroplasty, Jones and associates (27,28) concluded that joint-specific pain, function, vitality, and general health were significantly improved 6 months following joint replacement and that age was not a significant determinant of pain or functional outcome. In addition, Chang and colleagues (29) concluded that THA is cost saving or, at worst, cost effective in improving quality-adjusted life expectancy both short and long term. Our results and those of others previously cited corroborate these findings that THA results in joint-specific pain reduction or elimination and improved function.

Musculoskeletal problems are one of the most common reasons for a patient to seek medical care from his or her primary care physician. The pain and functional limitations experienced by the patient with end-stage hip osteoarthritis are easily assessed and identified. THA has been shown to be effective in patients of all ages, including those over the age of 80 years. However, THA, particularly in elderly people, is not without risk. Both medical and hip-related complications do occur, although most are minor and resolvable. Comorbidities have to be identified and treated to minimize postoperative complications and mortality. On the basis of these study results and the literature focusing on patients over the age of 80 years, we conclude that THA is, indeed, a safe and effective procedure and that primary care physicians should not hesitate to refer the active, elderly patient to an experienced arthroplasty surgeon should their patient experience severe pain and limitation of function as a result of advanced hip arthritis.


    Acknowledgments
 
Address correspondence to L. Daniel Wurtz, MD, Indiana University School of Medicine, Department of Orthopaedic Surgery, 541 Clinical Drive—CL600, Indianapolis, IN 46202. E-mail: dwurtz{at}iupui.edu


    Footnotes
 
,

Received June 18, 2002

Accepted August 9, 2002


    References
 Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Rorabeck CH, Bourne RB, Paupacis A, et al. A double-blind study of 250 cases comparing cemented with cementless total hip arthroplasty. Cost-effectiveness and its impact on health-related quality of life. Clin Orthop.. 1994;298:156-164.
  2. Laupacis A, Feeny D, Detsky AS, Tugwell AX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluation. Can Med Assoc J.. 1992;146:473-481.[Abstract]
  3. Fehring TK, Rosenberg AG. Primary total hip arthroplasty: indications and contraindications. In Callaghan JJ, Rosenberg AG, Rubash HE, eds. The Adult Hip. Philadelphia: Lippincott–Raven; 1998:893–898.
  4. Bureau of Census Current Population Reports: Sixty-Five Plus in America. Washington, DC: US Government Printing Office (23-178 RV); 1993.
  5. Wilcock GK. Benefits of total hip replacement to the older patient and to the community. Br Med J.. 1978;2:37-39.
  6. Wilcock GK. Economic aspects of the demand for total hip replacement in the elderly. Age Ageing.. 1979;8:32-35.[Abstract/Free Full Text]
  7. Dripps RD, Lamont A, Eckenhoff JE. The role of anaesthesia in surgical mortality. JAMA.. 1961;178:261-266.
  8. Barrack RL, Mulroy RD, Jr, Harris WH. Improved cementing techniques and femoral component loosening in young patients with hip arthroplasty. J Bone Joint Surg.. 1992;74-B:385-389.
  9. Brooker AF, Bowerman JW, Robinson RA, Riley LH, Jr. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg.. 1973;55-A:1629-1632.[Abstract/Free Full Text]
  10. Huddleston HD. Femoral lysis after cemented hip arthroplasty. J Arthroplast.. 1988;:3:285-287.
  11. Rothschild KM, Bates DW, Leape LL. Preventable medical injuries in older patients. Arch Intern Med.. 2000;160:2717-2728.[Abstract/Free Full Text]
  12. Jin F, Chung F. Minimizing perioperative adverse events in the elderly. Br J Anaesthes.. 2001;87:608-1624.[Abstract/Free Full Text]
  13. Keisu KS, Orozco F, Sharkey PF, Hozack WJ, Rothman RH. Primary cementless total hip arthroplasty in octogenarians. Two to eleven-year follow-up. J Bone Joint Surg.. 2001;83-A:359-362.[Abstract/Free Full Text]
  14. Brander VA, Malhotra S, Jet J, Heinemann AW, Stulberg SD. Outcome of hip and knee arthroplasty in persons aged 80 years and older. Clin Orthop.. 1997;345:67-78.
  15. Imamura K, Black N. Does comorbidity affect the outcome of surgery? Total hip replacement in the UK and Japan. Intl J Qual Health Care.. 1998;10:113-123.[Abstract/Free Full Text]
  16. Woolson ST, Rahimtoola ZO. Risk factors for dislocation during the first 3 months after total hip arthroplasty. J Arthroplast.. 1999;14:662-668.
  17. Khan MA, Brakenbury PH, Reynolds ISR. Dislocation following total hip arthroplasty. J Bone Joint Surg.. 1981;63-B:214-218.
  18. Kristiansen B, Jorgensen L, Holmich P. Dislocation following total hip replacement. Arch Orthop Trauma Surg.. 1985;103:375-377.
  19. Woo RYH, Morrey BG. Dislocations after total hip arthroplasty. J Bone Joint Surg.. 1982;64-A:1295-1306.[Abstract/Free Full Text]
  20. Mohler CG, Collis DK. Early complications and their management. In Callaghan JJ, Rosenberg AG, Rubash HE, eds. The Adult Hip. Philadelphia: Lippincott–Raven; 1998:1125–1147.
  21. Levy RN, Levy CM, Snyder J, Digiovanni J. Outcome and long-term results following total hip replacement in elderly patients. Clin Orthop.. 1995;316:25-30.
  22. Phillips TW, Grainger RW, Cameron HS, Bruce L. Risks and benefits of elective hip replacement in the octogenarian. Can Med Assoc J.. 1987;137:497-500.[Abstract]
  23. Newington DP, Bannister GC, Fordyce M. Primary total hip replacement in patients over 80 years of age. J Bone Joint Surg.. 1990;72-B:450-452.
  24. Pettine KA, Aamlid BC, Cabanela ME. Elective total hip arthroplasty in patients older than 80 years of age. Clin Orthop.. 1991;266:127-132.
  25. Whittle J, Steinberg EP, Anderson GF, Herbert R, Hochberg MC. Mortality after elective total hip arthroplasty in elderly Americans. Age, gender, and indication for surgery predict survival. Clin Orthop.. 1993;295:119-126.
  26. Ritter MA, Albohm MJ, Keating EM, Faris PM, Meding JB. Life expectancy after total hip arthroplasty. J Arthroplast.. 1998;13:874-875.
  27. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. Health related quality of life outcomes after total hip and knee arthroplasties in a community based population. J Rheumatol.. 2000;27:1745-1752.[Medline]
  28. Jones CA, Voaklander DC, Johnston DW, Suarez-Almazor ME. The effect of age on pain, function, and quality of life after total hip and knee arthroplasty. Arch Intern Med.. 2001;161:454-460.[Abstract/Free Full Text]
  29. Change RW, Pellissier JM, Hazen GB. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA.. 1996;275:858-865.[Abstract/Free Full Text]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Services
Right arrow Download to citation manager
PubMed
Right arrow PubMed Citation


HOME ARCHIVE SEARCH TABLE OF CONTENTS